A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
Clinical trial NCT02329847 · COMPLETED
Trial details
- NCT number
- NCT02329847
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-11
- Primary completion
- 2022-02-09
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.